Recent research has identified DSS1 as a significant driver gene in the metastasis of clear cell renal cell carcinoma (ccRCC). The study, conducted...
After being diagnosed with stage 2 melanoma, Teddi Mellencamp has been honest with her supporters about her journey. Here's the truth about her hea...
Recent research has developed a novel biomarker-based prostate cancer risk score that operates independently of body mass index (BMI). This study a...
Lantern Pharma has reported a complete metabolic response in a heavily pre-treated patient with aggressive Grade 3 non-germinal center B-cell diffu...
Recent research has identified the PNMA1 gene as a key factor in mediating chemoresistance in retinoblastoma, a type of eye cancer, by promoting DN...
Oncolytics Biotech Inc., a clinical-stage company specializing in immunotherapy for oncology, has regained compliance with Nasdaq's minimum bid pri...
AstraZeneca has announced positive results from the FLAURA2 Phase III trial, demonstrating that TAGRISSO (osimertinib) combined with chemotherapy s...
UK biotech company Scancell has announced promising data from a phase 2 trial of its DNA plasmid vaccine for melanoma, SCIB1 and iSCIB1+. The trial...
Recent research has highlighted the role of the receptor C5aR1 in helping tumor cells adapt to hypoxic conditions, which are common in tumor microe...
A phase 1b multicentre study is underway to evaluate the safety and pharmacokinetics of tilvestamab, a humanized anti-AXL antibody, in patients wit...